This
page is dedicated to “new” news about Leukemia research. Here you’ll find
information about some of the cutting edge stuff, not yet approved but
under investigation. Clinical trials and changes in treatment modalities
will be highlighted on occasion as well. It is the hope that one of these
items found on this page will one day be the answer for When Everyone Survives.
Click a link below for more information
New Leukemia Breakthroughs
Researchers Step Up Fight w/ Natural Killer Cells from Cord Blood - 8/08
Researchers Able to Generate Stem Cells from Skin Cells in Laboratory Mice - 6/07
Women Saved from Leukemia with Umbilical Cord Blood - 2/07
Indian Black Scorpion Venom shows Promise - 12/2006
Flavopiridol Shows Potential w/MCL- 11/2006
Novel Cell Line Shows Promise for Molecular Targeted Therapy - 11/2006
New Lymphoma Research Tool - 11/2006
Combination of Cytotoxic Drugs Demand Further Evaluation for AML- 11/2006
Leukemia Predictor Studied - 10/2006
Cyclosporine Therapy May Be Beneficial for T-LGL Leukemia Patients - 10/2006
Quantum Dots Now Identified as Useful Hematologic Tool - 10/2006
Nitric Oxide May Prove to Hold Promise as Anti -leukemic Agent - 10/2006
Remarkable Activity of Imatinib on CML seems apparent - 10/2006
Post Remission Treatment Improves Long Term Survival of APL Patients - 9/2006
Gene Expression Key to AML Prognosis - 9/2006
ZOL Investigated for Treatment of AML - 8/2006
Appropriateness of Leukemia Labeling Studied - 8/2006
Chromosome 13's Link to CML-BP - 8/2006
Imatinib Mesylate in BCR/ABL-positive AML May Be Long Lasting - 8/2006
Monotherapy with Low-Dose Azacytidine Provided Positive Results - 8/2006
Enzyme Induces Apoptosis - 8/2006
Sorcin Gene Important in Development of MDR Leukemia Cells 4/2006
Anti-SCF Enhances Chemotherapy in Some AML Patients 3/2006
TLR-7's
Effect on Human "B" Cells 3/2006
Can Harnessing ATF2 Improve Cancer Cell Sensitivity to Chemo and Radiation? 3/2006
T-cell
Immune Potential Increases Antibody Efficiency 2/2006
AML
Facts 08/2005
Obesity
Linked to Leukemia 8/2005
Effects of Translocation (t8,21) Inhibits Tumor Suppressor Activity in Myelocytic
Leukemia Cells 4/2003
Ongoing Clinical Trials
Tungsten Connection Research - 8/2006
Herbal Extract Being studied as adjunct therapy - 7/2006
Drug Similar to Gleevec in Trials for CML 7/2006
Troxacitabine hopes to show promise in AML 7/2006
Lintuzumab being tested in AML cases 7/2006
Radiation and Ara-C Combination in Clinical Trials 7/2006
Vaccine Being Tested for CML Patients with Philadelphia Chromosome 7/2006
Opposing Gene Expressions May Provide Research Triggers 6/2006
Green Tea Involvement Encourages Clinical Trial 6/2006
Par-4 Biology May Be Significant in Overcoming Drug Resistant Cancers 5/2006
Ongoing Trials at Emory 4/06
Tetrandrine Added to Conventional Therapy Shows Promise 4/2006
Tea Root Extract Continues to Show Anticancer Activity in Leukemia Test 4/2006
AML/Specific Clincal Trials 3/2006
Drug Trial to Reduce GVHD post Stem Cell Transplant 2/2006
Opposing Effects of Aspirin and Acetaminophen Use as Related to Leukemic Risk 2/2006
Mylotarg/Ara-C Trial for Relapsed AML 1/2006
Peripheral Blood Cells Better Than Bone Marrow For Transplants? 5/2005
Trial to Test AML Vaccine after First Remission 10/2004
|
